捆绑SM社区

Chris Greenaway is an infectious disease physician, clinician researcher and internationally recognized expert in migrant health. Her research program has focused on identifying and addressing the infectious disease health disparities among migrants. The overall objective of her research program is to promote the health of the migrant population and decrease their health disparities. To achieve this she has conducted observational studies, retrospective cohort studies with large linked administrative datasets, systematic reviews, economic analyses and has developed screening and clinical guidelines for migrants in Canada and Europe using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology.

Chris has a long standing interest in TB and been involved in clinical care of patients with TB for almost 20 years. She established the TB clinic at the Jewish General Hospital in 2001. She has conducted research related to the diagnosis and treatment of TB and the TB burden and screening strategies for the migrant population. She has written screening guidelines for active and latent TB for the Canadian Collaboration for Immigrant and Refugee Health (CMAJ 2011) and for the European Centers for Disease Control (2018 ). She is a co-PI on a multi-province CIHR funded study (2017-2020) that is using linked administrative databases to develop a risk prediction tool for the development of active TB among migrants. This data will be used to determine the most cost-effective screening and treatment strategy to achieve TB elimination in Canada.

听

听

Keywords

Migrant health, health disparities, infectious diseases, tuberculosis, screening听

Selected Publications

1. Greenaway C*, Pareek M, Abou Chakra N, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, Noori T, van der Werf MJ, Pottie K, Matteelli A, Zenner D, Morton RL. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance 2018 Apr 5; 23(14): 17-00542. DOI: . (IF 5.983)
2. Greenaway C*, Pareek M, Abou Chakra N, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, van der Werf MJ, Noori T, Pottie K, Matteelli A, Zenner D, Morton RL. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance 2018 Apr 5;23(14). DOI: 23/1560-7917.ES.2018.23.14.17-00543. (IF 5.983)
3. Pareek M, Greenaway C, Noori T, Munoz J, Zenner D, The impact of migration on tuberculosis epidemiology and control: a review. BMC Medicine. 2016;14(1):48. doi: 10.1186/s12916-016-0595-5. (IF 9.088)
4. Cheng M, Abou Chakra N, -Yansouni C, Cnossen S, Shrier I, Menzies D, Greenaway C*. Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis. Clinical Infectious Disease 2017; 64 (5):635-644. (IF 9.117)
5. Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies R, Vadeboncoeur C, Vissandj茅e B, Wynne A, Schwartzman K. Health-related quality of life and tuberculosis: a longitudinal cohort study. Health Qual Life Outcomes. 2015; 13(1):65. (IF 2.278)
6. Rubinowicz A, Bartlett G, MacGibbon B, Greenaway C, Ronald L, Munoz M, Menzies D. Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study. Int J Tuberc Lung Dis. 2014;18(12):1449-54. (IF 2.468)
7. Greenaway C*, Sandoe A, Vissandjee B, Kitai I, Gruner D, Wobeser W, Pottie K, Ueffing E, Menzies D, Schwartzman K. Tuberculosis: Evidence Review for Newly Arriving Immigrants and Refugees. CMAJ. 2011 Sep 6: 183(12):E939-51.

听

听

External Links